- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/13 - Cyclosporins
Patent holdings for IPC class A61K 38/13
Total number of patents in this class: 1184
10-year publication summary
|
83
|
105
|
103
|
105
|
112
|
127
|
145
|
115
|
92
|
28
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2600 |
61 |
| Novartis AG | 11238 |
28 |
| Saint Regis Mohawk Tribe | 34 |
25 |
| Breath Therapeutics GmbH | 27 |
22 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
20 |
| Sublimity Therapeutics Limited | 39 |
17 |
| The Regents of the University of California | 18943 |
16 |
| Aurinia Pharmaceuticals Inc. | 80 |
15 |
| Novaliq GmbH | 165 |
14 |
| Hepion Pharmaceuticals, Inc. | 22 |
14 |
| The General Hospital Corporation | 4517 |
12 |
| Schepens Eye Research Institute | 64 |
12 |
| Farsight Medical Technology (Shanghai) Co., Ltd. | 18 |
12 |
| MannKind Corporation | 531 |
11 |
| Scynexis, Inc. | 69 |
11 |
| Selecta Biosciences, Inc. | 190 |
11 |
| Aneira Pharma, Inc. | 13 |
11 |
| Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | 22 |
10 |
| Biora Therapeutics, Inc. | 95 |
10 |
| Enanta Pharmaceuticals, Inc. | 420 |
9 |
| Other owners | 843 |